{"id":"W2078786399","doi":"10.1182/blood-2011-05-352039","title":"Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Decitabine; Chronic myelomonocytic leukemia; Medicine; Internal medicine; Oncology; Neuroblastoma RAS viral oncogene homolog; Azacitidine; KRAS; Hypomethylating agent; Leukemia; Phases of clinical research; Myelodysplastic syndromes; Clinical trial; Bone marrow; Biology; Cancer; Gene; DNA methylation; Gene expression","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001966752,0.001307389,0.001254974,0.0004124858,0.0002285664,0.0008413502,0.0005707904,0.001143441,0.002396522],"category_scores_gemma":[0.001118337,0.0003463574,0.0007676306,0.0003226511,0.0004513468,0.000591956,0.0003154543,0.001672054,0.0004132907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006560076,"about_ca_system_score_gemma":0.0007471449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004521768,"about_ca_topic_score_gemma":0.0008713141,"domain_scores_codex":[0.9996288,0.0002092738,0.00001623039,0.00005356028,0.00003238156,0.00005969351],"domain_scores_gemma":[0.9993126,0.0001735036,0.0001553632,0.0000489296,0.00004673475,0.0002628347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8207284,0.02941992,0.01361874,0.0007816253,0.001218735,0.0002484436,0.0001973342,0.00271789,0.0209805,0.0003596024,0.003624369,0.1061043],"study_design_scores_gemma":[0.7446623,0.2209637,0.02421712,0.00009071353,0.0004988365,0.0002671172,0.00004525219,0.002805708,0.002352976,0.0003054673,0.003752496,0.00003829246],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933255,0.002802984,0.0002447032,0.0004612315,0.0000849074,0.00140145,0.0007846374,0.00004488619,0.0008497086],"genre_scores_gemma":[0.9860808,0.003057997,0.001602133,0.0009868854,0.0002311728,0.002988787,0.002746671,0.00002390962,0.002281654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002396522,"threshold_uncertainty_score":0.01040137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02385382553336404,"score_gpt":0.3125065866548258,"score_spread":0.2886527611214618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}